BIOLOGICAL · Unmapped registry intervention
allo-APZ2-DFU
Find medicine records ·
Find other trials using this name
Clinical trial
Allogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"
NCT03267784
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedAllogeneic ABCB5-positive Stem Cells for Treatment of DFU "Malum Perforans"
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetic Neuropathic Ulcerunresolved
Interventions
allo-APZ2-DFUBIOLOGICAL
Sponsors & collaborators
RHEACELL GmbH & Co. KGlead sponsor
FGK Clinical Research GmbHcollaborator
Ticeba GmbHcollaborator
Granzer Regulatory Consulting & Servicescollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03267784 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.